ANIP vs XEL · rev $503.5M vs P/E 20, $39.33B cap
ANI Pharmaceuticals Inc (ANIP) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
Latest reported ANIP revenue for 2026-06-30 was $503.5M. Net income was $54.2M. ANIP currently screens at market cap $1.41B.
XEL does not have a complete income-statement cache yet.
ANIP currently screens at market cap $1.41B. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the ANIP and XEL stock pages for the full models.
Not investment advice.